700,000 Shares in InfuSystem Holdings, Inc. $INFU Acquired by Heartland Advisors Inc.

Key Points

• Heartland Advisors acquired 700,000 InfuSystem shares worth approximately $6.76 million, giving it a 3.47% stake. Institutional investors and hedge funds collectively own 71.13% of the company.
• InfuSystem shares opened at $12.21, near their 12-month high of $12.97, while the company has authorized a $20 million share buyback covering up to 10.2% of outstanding shares.
• Analyst sentiment remains positive: B. Riley raised its price target to $20 from $12, and the stock carries a “Moderate Buy” consensus rating with an average target of $16.67.

Heartland Advisors Inc. acquired a new stake in shares of InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 700,000 shares of the company's stock, valued at approximately $6,755,000. Heartland Advisors Inc. owned approximately 3.47% of InfuSystem as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Quarry LP bought a new stake in InfuSystem in the fourth quarter worth approximately $31,000. Raymond James Financial Inc. acquired a new position in shares of InfuSystem during the 2nd quarter worth $33,000. Virtu Financial LLC bought a new position in shares of InfuSystem during the 4th quarter valued at $90,000. LPL Financial LLC bought a new position in shares of InfuSystem during the 4th quarter valued at $92,000. Finally, Boothbay Fund Management LLC acquired a new stake in shares of InfuSystem in the 4th quarter valued at $98,000. 71.13% of the stock is currently owned by institutional investors and hedge funds.

InfuSystem Stock Up 0.1%

Shares of InfuSystem stock opened at $12.21 on Friday. The stock has a market capitalization of $246.42 million, a P/E ratio of 203.53 and a beta of 1.42. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average price of $10.17 and a two-hundred day moving average price of $9.52. InfuSystem Holdings, Inc. has a 12-month low of $7.29 and a 12-month high of $12.97.

InfuSystem declared that its board has authorized a share buyback program on Tuesday, May 19th that permits the company to buyback $20.00 million in shares. This buyback authorization permits the company to buy up to 10.2% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

Separately, B. Riley Financial reiterated a "buy" rating and issued a $20.00 price objective (up from $12.00) on shares of InfuSystem in a report on Wednesday, August 5th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, InfuSystem has an average rating of "Moderate Buy" and a consensus price target of $16.67.

InfuSystem Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem's offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source